Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127460601 | 12746060 | 1 | I | 20110725 | 20160907 | 20160915 | 20160915 | EXP | US-AMNEAL PHARMACEUTICALS-2016AMN00532 | AMNEAL | 63.00 | YR | M | Y | 0.00000 | 20160915 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127460601 | 12746060 | 1 | PS | NAPROXEN. | NAPROXEN | 1 | UNK | 75927 | |||||||||||
| 127460601 | 12746060 | 2 | SS | NAPROXEN. | NAPROXEN | 1 | 75927 | ||||||||||||
| 127460601 | 12746060 | 3 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | UNK | Y | 0 | ||||||||||
| 127460601 | 12746060 | 4 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 0 | ||||||||||||
| 127460601 | 12746060 | 5 | C | HYZAAR | HYDROCHLOROTHIAZIDELOSARTAN POTASSIUM | 1 | UNK | 0 | |||||||||||
| 127460601 | 12746060 | 6 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | UNK | 0 | |||||||||||
| 127460601 | 12746060 | 7 | C | ASPIRIN. | ASPIRIN | 1 | UNK | 0 | |||||||||||
| 127460601 | 12746060 | 8 | C | LOPRESSOR | METOPROLOL TARTRATE | 1 | UNK | 0 | |||||||||||
| 127460601 | 12746060 | 9 | C | NIACIN. | NIACIN | 1 | UNK | 0 | |||||||||||
| 127460601 | 12746060 | 10 | C | FOLIC ACID. | FOLIC ACID | 1 | UNK | 0 | |||||||||||
| 127460601 | 12746060 | 11 | C | iron | IRON | 1 | UNK | 0 | |||||||||||
| 127460601 | 12746060 | 12 | C | multivitamins | VITAMINS | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127460601 | 12746060 | 1 | Osteoarthritis |
| 127460601 | 12746060 | 2 | Rheumatoid arthritis |
| 127460601 | 12746060 | 5 | Hypertension |
| 127460601 | 12746060 | 7 | Coronary artery disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127460601 | 12746060 | OT |
| 127460601 | 12746060 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127460601 | 12746060 | Acute coronary syndrome | |
| 127460601 | 12746060 | Chest pain | |
| 127460601 | 12746060 | Dyspnoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127460601 | 12746060 | 1 | 20100429 | 20110124 | 0 | |
| 127460601 | 12746060 | 3 | 20110124 | 0 | ||
| 127460601 | 12746060 | 5 | 2011 | 0 | ||
| 127460601 | 12746060 | 6 | 2003 | 0 | ||
| 127460601 | 12746060 | 7 | 2003 | 0 | ||
| 127460601 | 12746060 | 8 | 2009 | 0 | ||
| 127460601 | 12746060 | 9 | 2002 | 0 | ||
| 127460601 | 12746060 | 10 | 2002 | 0 | ||
| 127460601 | 12746060 | 11 | 2002 | 0 | ||
| 127460601 | 12746060 | 12 | 2002 | 0 |